19th Congress of the European Society for Dermatology and Psychiatry (ESDaP) and 2nd Brain Skin Colloquium Conference (BSC), June 11–13, 2021, London

Authors

  • Anthony Bewley Barts Health NHS Trust; and Queen Mary University London, Royal London Hospital, London, UK
  • Richard Barlow University Hospitals Coventry and Warwickshire NHS Trust
  • Alia Ahmed Barts Health NHS Trust
  • Padma Mohandas Barts Health NHS Trust

DOI:

https://doi.org/10.2340/actadv.v101.872

Keywords:

psychodermatology, psychocutaneous medicine, quality of life, psychosocial co-morbidities

Abstract

The Congress of the European Society for Dermatology and Psychiatry (ESDaP), held in conjunction with the 2nd Brain Skin Colloquium (BSC) Conference, hosted over 60 speakers delivering 47 oral presentations, 41 poster presentations and 5 keynote talks via 2 simultaneous livestream platforms. The 2-day conference, held biennially, was due to be hosted in London, but was converted to a virtual format due to the Covid-19 pandemic. This report presents a synopsis of the conference.

Downloads

Download data is not yet available.

References

Dalgard F. Characteristics of patients seen at a psychodermatology unit in Sweden. In: Brain: Skin Colloquium 2021; 2021 June. Available from http://www.esdap21.com/home.

Jafferany M. Depression and Psoriasis: How to Diagnose and manage. In: Brain: Skin Colloquium 2021; 2021 June. Available from http://www.esdap21.com/home.

Bullmore E. Inflammation and depression. In: Brain: Skin Colloquium 2021; 2021 June. Available from http://www.esdap21.com/home.

Griffiths C. Insights into the Brain-Skin Axis. In: Brain: Skin Colloquium 2021; 2021 June. Available from http://www.esdap21.com/home.

Kirby B. Psoriasis and Mindfulness. In: Brain: Skin Colloquium 2021; 2021 June. Available from http://www.esdap21.com/home.

Yosipovitch G. Mechanisms of Itch and Its Management. In: ESDAP 2021; 2021 June. Available from http://www.esdap21.com/home.

Misery L. Pruriplastic Itch, An Equivalent of Nociplastic Pain. In: ESDAP 2021; 2021 June. Available from http://www.esdap21.com/home.

McGlone F. The Skin's Protectors: The 3 C's. In: ESDAP 2021; 2021 June. Available from http://www.esdap21.com/home

Evers A. Nocebo effects on itch as possible predictor of itch sensitization. In: Brain: Skin Colloquium 2021; 2021 June. Available from http://www.esdap21.com/home.

Thompson A. Lack of mental health support for UK skin disease patients: The 2020 All Party Parliamentary Group on Skin's report. In: Brain: Skin Colloquium 2021; 2021 June. Available from http://www.esdap21.com/home.

Finlay A. Family impact: the hidden burden revealed by FROM-16. In: ESDAP 2021; 2021 June. Available from http://www.esdap21.com/home.

Bundy C. Structured Psychological Support for Dermatology Patients and Adaptations During the SARS-CoV-2 Pandemic. In: Brain: Skin Colloquium 2021; 2021 June. Available from http://www.esdap21.com/home.

Flohr C. COVID-19 in AD: lessons from the SECURE-AD physician and patient registries. In: Brain: Skin Colloquium 2021; 2021 June. Available from http://www.esdap21.com/home.

Cooper C. Wellbeing in the workplace. In: ESDAP 2021; 2021 June. Available from http://www.esdap21.com/home.

Poot F, Sampogna F, Tomas-Aragones L & Gieler U. The psychodermatology diploma: comparing the online versus the face-to-face experience. Br J Dermatol 2021; 185: e86.

Ahmed A. Single-centre experience of setting up a psychodermatology clinic: making the most of what you have. Br J Dermatol 2021; 185: e83.

Capdevila P, Lopez-Trujillo E, Tribo MJ & Pujol RM. Psychopathological profile and responseto combined therapy with mirtazapine and sertraline in patients with somatoform pruritus. Br J Dermatol 2021; 185: e74.

Schmidt LEM, Merdha L, Lang V, Preis S, Bleuel R, Schuch A et al. A qualitative study on maternal attachment behaviour as a risk factor for the onset of atopic dermatitis in theinfant. Br J Dermatol 2021; 185: e73.

Day M, Heapy C, Norman P, Emerson LM, Murphy R & Thompson A . Impact of childhood psoriasis on children and parents: an interpretative phenomenological analysis. Br J Dermatol 2021; 185: e71.

Birkjær M, Thomsen SF, Cernica C, Bewley A & Bainton A. Using life evaluation to revise the Dermatology Life Quality Index: a multinational survey of patients with psoriasis. Br J Dermatol 2021; 185: e70.

Krajewski P, Matusiak Ł, von Stebut E, Schultheis M, Kirschner U, Nikolakis G et al. Decrease in quality of life among patients with hidradenitis suppurativa: a cross-sectional study of 1795 patients. Br J Dermatol 2021; 185: e77.

https://doi.org/10.3390/life11010034

Rachael P, Rachael H, Trialonis-Suthakharan N, Chachos E, Augustin M & Bundy C. Defining, understanding and measuring the impact of dermatological conditions on patients' lives: a qualitative concept elicitation study for a new patient-reported impact of dermatological disease (PRIDD) measure. Br J Dermatol 2021; 185: e83.

Hewitt R, Pattinson R, Cordingley L, Griffiths C, Kleyn E, McAteer H et al. Implementation of the PsoWellTM model for the management of people with complex psoriasis. Br J Dermatol (in Press). Br J Dermatol 2021; 185: e72.

https://doi.org/10.2340/00015555-3802

Lander K, Harris C, Al-Attar A & Kleyn E. Eczema and interpersonal avoidance. Br J Dermatol 2021; 185: e73.

Brookes T S-R, Barlow R, Mohandas P & Bewley A. Topical steroid withdrawal: an emerging clinical problem. Br J Dermatol 2021; 185: e74.

Tanev T. Social media and self-perception: a psychodermatological perspective. Br J Dermatol 2021; 185: e87.

Schut C, Dalgard FJ, Bewley A, Evers AWM, Gieler U, Lien L et al. Prevalence of symptoms of body dysmorphic disorder in patients with dermatological conditions compared to healthy skin controls: results of the ESDAP-study-II. Br J Dermatol 2021; 185: e81.

Al-Sarraf A, Bewley A & Corazza O. Skin tone lightening: a psychodermatological problem? Br J Dermatol 2021; 185: e76.

Bewley A, Thyssen JP, Chiu WS, Rojo R, Biswas P, Feeney C et al. Impact of abrocitinib on itch, sleep, skin pain and psychological stress in patients with moderate-to-severe atopic dermatitis: pooled analysis from JADE monotherapy trials. Br J Dermatol 2021; 185: e72.

Shinhmar S, Lawrence L & Bewley A. The impact of the COVID-19 pandemic on psychodermatology patients. Br J Dermatol 2021; 185: e90.

Walsh C, Leavey G & McLaughlin M. Informing the development of a Needs Assessment Tool for Ichthyosis Caregivers (NAT-IC): an international multimethod qualitative study using framework analysis. Br J Dermatol 2021; 185: e79.

Barlow R, Payyazhi G, Hogan S, Grindlay D, Verma M, Choi D et al. Suicide and suicidality in children and adolescents with chronic skin disorders: a systematic review. Br J Dermatol 2021; 185: e97.

Lada G, Talbot PS, Chinoy H, Warren RB & Kleyn CE. Clinical correlates of depression and anxiety in psoriasis and prevalence of undiagnosed depression. Br J Dermatol 2021; 185: e71.

Williams P & Dimitrov D. Suicide: last resort for the prisoners trapped in ill skin. Br J Dermatol 2021; 185: e76.

Shatokhina E, Kruglova L & Polonskaia A. Efficacy of dupilumab in patients with immune checkpoint inhibitor-related pruritus. Br J Dermatol 2021; 185: e101.

Moschogianis S, Chisholm A, McKie S, Griffiths C, Elliott R & Kleyn E. Towards an understanding of the psychosocial impact of psoriasis. Br J Dermatol 2021; 185: e103.

Fellows JL, Harper N, Mortimer H & Goulding JMR. Potential utility of eye movement desensitization and reprocessing and the flash technique in psychodermatology. Br J Dermatol 2021; 185: e104.

Downloads

Published

2022-03-15

How to Cite

Bewley, A., Barlow, R., Ahmed, A., & Mohandas, P. (2022). 19th Congress of the European Society for Dermatology and Psychiatry (ESDaP) and 2nd Brain Skin Colloquium Conference (BSC), June 11–13, 2021, London. Acta Dermato-Venereologica, 102, adv00670. https://doi.org/10.2340/actadv.v101.872

Issue

Section

Special report

Categories